These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19694199)

  • 1. Impairment in anthropometric parameters and body composition in females with classical 21-hydroxylase deficiency.
    Gonçalves EM; de Lemos-Marini SH; de Mello MP; Baptista MT; D'Souza-Li LF; Baldin AD; Carvalho WR; Farias ES; Guerra-Junior G
    J Pediatr Endocrinol Metab; 2009 Jun; 22(6):519-29. PubMed ID: 19694199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Körner A; Kiess W; Kratzsch J; Dörr HG
    Acta Paediatr; 2009 May; 98(5):885-91. PubMed ID: 19236311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Body composition in females with 21-hydroxylase deficiency: comparison of anthropometric methods and bioelectric impedance in relation to a control group].
    Gonçalves EM; Lemos-Marini SH; Mello MP; Baldin AD; Carvalho WR; Farias ES; Guerra-Júnior G
    Arq Bras Endocrinol Metabol; 2010 Mar; 54(3):274-81. PubMed ID: 20520957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasia.
    Verma S; Green-Golan L; VanRyzin C; Drinkard B; Mehta SP; Weise M; Eisenhofer G; Merke DP
    Horm Metab Res; 2010 Jul; 42(8):607-12. PubMed ID: 20446239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ENERGY EXPENDITURE IN 21-HYDROXYLASE CONGENITAL ADRENAL HYPERPLASIA PATIENTS AND COMPARISON WITH PREDICTIVE EQUATIONS.
    de Oliveira DM; Vasques ACJ; Gonçalves EM; de Lemos-Marini SHV; Guerra-Junior G; Geloneze B
    Endocr Pract; 2020 Apr; 26(4):388-398. PubMed ID: 31859548
    [No Abstract]   [Full Text] [Related]  

  • 7. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
    Manoli I; Kanaka-Gantenbein Ch; Voutetakis A; Maniati-Christidi M; Dacou-Voutetakis C
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density and body composition in congenital adrenal hyperplasia.
    Cameron FJ; Kaymakci B; Byrt EA; Ebeling PR; Warne GL; Wark JD
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density and body composition in prepubertal and adolescent patients with the classical form of 21-hydroxylase deficiency.
    Sahakitrungruang T; Wacharasindhu S; Supornsilchai V; Srivuthana S; Kingpetch K
    J Med Assoc Thai; 2008 May; 91(5):705-10. PubMed ID: 18672636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia.
    Marra AM; Improda N; Capalbo D; Salzano A; Arcopinto M; De Paulis A; Alessio M; Lenzi A; Isidori AM; Cittadini A; Salerno M
    J Clin Endocrinol Metab; 2015 Feb; 100(2):644-52. PubMed ID: 25405496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency.
    Ariyawatkul K; Tepmongkol S; Aroonparkmongkol S; Sahakitrungruang T
    Eur J Pediatr; 2017 Apr; 176(4):537-545. PubMed ID: 28224294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Falhammar H; Filipsson H; Holmdahl G; Janson PO; Nordenskjöld A; Hagenfeldt K; Thorén M
    J Clin Endocrinol Metab; 2007 Jan; 92(1):110-6. PubMed ID: 17032717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
    Hargitai G; Sólyom J; Battelino T; Lebl J; Pribilincová Z; Hauspie R; Kovács J; Waldhauser F; Frisch H;
    Horm Res; 2001; 55(4):161-71. PubMed ID: 11598369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density.
    de Almeida Freire PO; de Lemos-Marini SH; Maciel-Guerra AT; Morcillo AM; Matias Baptista MT; de Mello MP; Guerra G
    J Bone Miner Metab; 2003; 21(6):396-401. PubMed ID: 14586796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report.
    Roche EF; Charmandari E; Dattani MT; Hindmarsh PC
    Clin Endocrinol (Oxf); 2003 May; 58(5):589-96. PubMed ID: 12699440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of adrenomedullary function in patients with congenital adrenal hyperplasia.
    Tutunculer F; Saka N; Arkaya SC; Abbasoglu S; Bas F
    Horm Res; 2009; 72(6):331-6. PubMed ID: 19844121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalization of height and excess body fat in children with salt-wasting 21-hydroxylase deficiency.
    Mendes-Dos-Santos CT; Lemos-Marini SH; Baptista MT; Guerra-Junior G; De-Mello MP; Paulino MF; Morcillo AM
    J Pediatr (Rio J); 2011 May-Jun 8; 87(3):263-8. PubMed ID: 21660369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Falhammar H; Filipsson Nyström H; Wedell A; Thorén M
    Eur J Endocrinol; 2011 Feb; 164(2):285-93. PubMed ID: 21098686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty.
    Charmandari E; Hindmarsh PC; Johnston A; Brook CG
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2701-8. PubMed ID: 11397874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of anthropometric measurements in estimating fat mass in individuals with 21-hydroxylase deficiency.
    Gonçalves EM; Silva AM; Santos DA; Lemos-Marini SH; de Oliveira Santos A; Mendes-Dos-Santos CT; De-Mello MP; Guerra-Júnior G
    Nutrition; 2012 Oct; 28(10):984-90. PubMed ID: 22516373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.